City-wide Surveillance for the Occurrence of Respiratory Syncytial Virus(RSV) Respiratory Tract Infections in a Population of High Risk Infants ≤32 weeks Gestational Age † 1453

被引：0
|
作者：
Janine Y Khan
Beverly S Brozanski
机构：
[1] RSV Pittsburgh Consortium,Department of Pediatrics
[2] University of Pittsburgh,undefined
[3] Magee-Womens Research Institute,undefined
来源：
Pediatric Research | 1998年 / 43卷 / Suppl 4期
关键词：
D O I：
10.1203/00006450-199804001-01474
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：248 / 248
相关论文
共 50 条
  • [1] Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections
    Rodriguez, WJ
    Gruber, WC
    Welliver, RC
    Groothuis, JR
    Simoes, EAF
    Meissner, HC
    Hemming, VG
    Hall, CB
    Lepow, ML
    Rosas, AJ
    Robertsen, C
    Kramer, AA
    Kim, HW
    Arrobio, J
    Milburn, C
    Baker, J
    Satterwhite, P
    Steel, L
    Bender, P
    King, S
    Levin, M
    Aronoff, S
    Baer, L
    Sanchez, J
    Top, FH
    Hensen, SA
    Peterson, MB
    PEDIATRICS, 1997, 99 (03) : 454 - 461
  • [2] Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?
    Carbonell-Estrany, Xavier
    Fullarton, John R.
    Rodgers-Gray, Barry S.
    Gooch, Katherine L.
    Vo, Pamela G.
    Figueras-Aloy, Jose
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (10): : 1133 - 1141
  • [3] The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age
    Doering, Gunther
    Gusenleitner, Walter
    Belohradsky, Bernd H.
    Burdach, Stefan
    Resch, Bernhard
    Liese, Johannes G.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (12) : 1188 - 1190
  • [4] Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era
    Resch, Bernhard
    Egger, Beatrice
    Kurath-Koller, Stefan
    Urlesberger, Berndt
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 57 : 50 - 53
  • [5] Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
    B. Resch
    V. S. Bramreiter
    S. Kurath-Koller
    T. Freidl
    B. Urlesberger
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 1057 - 1062
  • [6] Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
    Resch, B.
    Bramreiter, V. S.
    Kurath-Koller, S.
    Freidl, T.
    Urlesberger, B.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (06) : 1057 - 1062
  • [7] Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age
    Resch, B
    Pasnocht, A
    Gusenleitner, W
    Müller, W
    JOURNAL OF INFECTION, 2005, 50 (05) : 397 - 403
  • [8] Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age
    X. Carbonell-Estrany
    L. Bont
    G. Doering
    J-B. Gouyon
    M. Lanari
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27
  • [9] Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age
    Carbonell-Estrany, X.
    Bont, L.
    Doering, G.
    Gouyon, J-B
    Lanari, M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (10) : 891 - 899
  • [10] Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey
    Paes, Bosco
    Lanctot, Krista
    TURKISH JOURNAL OF PEDIATRICS, 2013, 55 (05) : 564 - 567
12345